Theracurmin HP

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
2	筋萎縮性側索硬化症	1

2. 筋萎縮性側索硬化症

臨床試験数 : 645 / 薬物数 : 589 - (DrugBank : 163) / 標的遺伝子数 : 150 - 標的パスウェイ数 : 225

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04499963 (ClinicalTrials.gov)	August 28, 2020	31/7/2020	Trial of Theracurmin for Patients With Amyotrophic Lateral Sclerosis (ALS)	An Open-label, Single-center, 6-month Trial of Theracurmin for Patients With Amyotrophic Lateral Scl ...	Amyotrophic Lateral Sclerosis	Drug: Theracurmin HP	Richard Bedlack, M.D., Ph.D.	NULL	Completed	18 Years	N/A	All	68	Phase 2	United States

First Previous1Next Last